Lumida
/ESPR
⌘K
Esperion Therapeutics Inc

Esperion Therapeutics Inc

ESPR
$3.18USD-0.31%-0.01 today

MARKET CAP

819.5M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$1
$4

AI Summary

Stalk
Buy NowMedium

We remain bullish across all horizons as ESPR sits in a Stage 2 advance with a fresh higher-high/higher-low structure driven by a Lockout Rally above rising EMAs. The active Lockout Rally override validates a Buy Now posture despite near-term extension, favoring participation on shallow retracements into the 9/20 EMA support zone. Moderate distribution risk exists as EMAs flatten near recent highs, warranting vigilance for a shift in momentum.

  • Merger with Essence MergerCo enhances scale, capital, and efficiency.
  • 30% of patients cannot tolerate statins, creating a large addressable market.
  • Trading suspended for the merger poses liquidity risk and uncertainty.
Full analysis →

Buying

6

institutions

Selling

10

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY22.13 M69.92 M+4.28 M+43.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW4.65 M14.71 M+4.65 M+0.0%0.02%
MM

Millennium Management LLC

Q2 2026

BUY2.23 M7.03 M+1.62 M+324.7%0.00%
PA

Polar Asset Management Partners Inc.

Q2 2026

BUYNEW1.51 M4.77 M+1.51 M+0.0%0.10%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.40 M4.40 M+711.19 K+144.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL835.05 K2.64 M+-110.96 K+1.8%0.00%
SF

Soros Fund Management LLC

Q2 2026

BUYNEW757.36 K2.39 M+757.36 K+0.0%0.04%
RT

Renaissance Technologies LLC

Q2 2026

SELL160.20 K506.23 K+-1.46 M-88.6%0.00%
WP

Woodline Partners LP

Q2 2026

SELL127.03 K401.41 K+-127.03 K-42.3%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL820.002.59 K+-1.79 K-63.8%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL0.000.00+-1.74 M-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-1.69 M-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-339.77 K-100.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL0.000.00+-314.87 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-46.14 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-21.40 K-100.0%0.00%